<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Nexalis Therapeutics Limited — News on 6ix</title>
    <link>https://6ix.com/company/nexalis-therapeutics-limited</link>
    <description>Latest news and press releases for Nexalis Therapeutics Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 19 Mar 2026 02:43:05 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/nexalis-therapeutics-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d5ae12beedb30cb6f9ac38.webp</url>
      <title>Nexalis Therapeutics Limited</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited</link>
    </image>
    <item>
      <title>First patient dosed in IRX-616a Phase 1 trial</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/first-patient-dosed-in-irx-616a-phase-1-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/first-patient-dosed-in-irx-616a-phase-1-trial</guid>
      <pubDate>Thu, 19 Mar 2026 02:43:05 GMT</pubDate>
      <description>First patient dosed in IRX-616a Phase 1 trial</description>
    </item>
    <item>
      <title>First eligible participant screened - phase 1 IRX-616a study</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/first-eligible-participant-screened-phase-1-irx-616a-study</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/first-eligible-participant-screened-phase-1-irx-616a-study</guid>
      <pubDate>Wed, 04 Mar 2026 05:47:10 GMT</pubDate>
      <description>First eligible participant screened - phase 1 IRX-616a study</description>
    </item>
    <item>
      <title>Preliminary Final Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/preliminary-final-report-441</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/preliminary-final-report-441</guid>
      <pubDate>Fri, 27 Feb 2026 11:55:09 GMT</pubDate>
      <description>Preliminary Final Report</description>
    </item>
    <item>
      <title>Dec25 Quarterly Activities Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/dec25-quarterly-activities-report-1</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/dec25-quarterly-activities-report-1</guid>
      <pubDate>Thu, 29 Jan 2026 07:45:06 GMT</pubDate>
      <description>Dec25 Quarterly Activities Report</description>
    </item>
    <item>
      <title>Dec25 Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/dec25-appendix-4c-cash-flow-report</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/dec25-appendix-4c-cash-flow-report</guid>
      <pubDate>Thu, 29 Jan 2026 07:37:03 GMT</pubDate>
      <description>Dec25 Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>IRX Overview Presentation - SRX-25 and Nexalis</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/irx-overview-presentation-srx-25-and-nexalis</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/irx-overview-presentation-srx-25-and-nexalis</guid>
      <pubDate>Wed, 10 Dec 2025 04:45:08 GMT</pubDate>
      <description>IRX Overview Presentation - SRX-25 and Nexalis</description>
    </item>
    <item>
      <title>$12.6m Facility to Drive SRX-25 Development</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/dollar126m-facility-to-drive-srx-25-development</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/dollar126m-facility-to-drive-srx-25-development</guid>
      <pubDate>Thu, 04 Dec 2025 03:51:06 GMT</pubDate>
      <description>$12.6m Facility to Drive SRX-25 Development</description>
    </item>
    <item>
      <title>Prospectus - Non-Renounceable Rights Issue Offer</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/prospectus-non-renounceable-rights-issue-offer-1</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/prospectus-non-renounceable-rights-issue-offer-1</guid>
      <pubDate>Wed, 26 Nov 2025 05:03:15 GMT</pubDate>
      <description>Prospectus - Non-Renounceable Rights Issue Offer</description>
    </item>
    <item>
      <title>Drug Development Pipeline Bolstered and Capital Raise</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/drug-development-pipeline-bolstered-and-capital-raise</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/drug-development-pipeline-bolstered-and-capital-raise</guid>
      <pubDate>Wed, 26 Nov 2025 05:02:04 GMT</pubDate>
      <description>Drug Development Pipeline Bolstered and Capital Raise</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/trading-halt-1499</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/trading-halt-1499</guid>
      <pubDate>Mon, 24 Nov 2025 03:49:15 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Sep25 Quarterly Activities Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/sep25-quarterly-activities-report-3</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/sep25-quarterly-activities-report-3</guid>
      <pubDate>Fri, 31 Oct 2025 10:52:04 GMT</pubDate>
      <description>Sep25 Quarterly Activities Report</description>
    </item>
    <item>
      <title>Sep25 Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/sep25-appendix-4c-cash-flow-report</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/sep25-appendix-4c-cash-flow-report</guid>
      <pubDate>Fri, 31 Oct 2025 10:48:04 GMT</pubDate>
      <description>Sep25 Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>Half Yearly Report and Accounts</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/half-yearly-report-and-accounts-561</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/half-yearly-report-and-accounts-561</guid>
      <pubDate>Mon, 25 Aug 2025 04:16:06 GMT</pubDate>
      <description>Half Yearly Report and Accounts</description>
    </item>
    <item>
      <title>Jun25 Quarterly Activities Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/jun25-quarterly-activities-report-3</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/jun25-quarterly-activities-report-3</guid>
      <pubDate>Tue, 22 Jul 2025 05:57:10 GMT</pubDate>
      <description>Jun25 Quarterly Activities Report</description>
    </item>
    <item>
      <title>Jun25 Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/jun25-appendix-4c-cash-flow-report</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/jun25-appendix-4c-cash-flow-report</guid>
      <pubDate>Tue, 22 Jul 2025 05:57:09 GMT</pubDate>
      <description>Jun25 Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>Mar25 Appendix 4C Cash Flow Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/mar25-appendix-4c-cash-flow-report</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/mar25-appendix-4c-cash-flow-report</guid>
      <pubDate>Mon, 28 Apr 2025 06:27:04 GMT</pubDate>
      <description>Mar25 Appendix 4C Cash Flow Report</description>
    </item>
    <item>
      <title>Mar25 Quarterly Activities Report</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/mar25-quarterly-activities-report-1</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/mar25-quarterly-activities-report-1</guid>
      <pubDate>Mon, 28 Apr 2025 06:27:04 GMT</pubDate>
      <description>Mar25 Quarterly Activities Report</description>
    </item>
    <item>
      <title>IRX Completes First Drawdown Under Clendon Facility</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/irx-completes-first-drawdown-under-clendon-facility</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/irx-completes-first-drawdown-under-clendon-facility</guid>
      <pubDate>Thu, 24 Apr 2025 05:41:03 GMT</pubDate>
      <description>IRX Completes First Drawdown Under Clendon Facility</description>
    </item>
    <item>
      <title>IRX-616a Study Order Executed to Commence Phase 1</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/irx-616a-study-order-executed-to-commence-phase-1</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/irx-616a-study-order-executed-to-commence-phase-1</guid>
      <pubDate>Thu, 17 Apr 2025 04:08:15 GMT</pubDate>
      <description>IRX-616a Study Order Executed to Commence Phase 1</description>
    </item>
    <item>
      <title>Study Order Executed for Phase 2 BTcP Trial</title>
      <link>https://6ix.com/company/nexalis-therapeutics-limited/news/study-order-executed-for-phase-2-btcp-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/nexalis-therapeutics-limited/news/study-order-executed-for-phase-2-btcp-trial</guid>
      <pubDate>Thu, 13 Mar 2025 08:11:04 GMT</pubDate>
      <description>Study Order Executed for Phase 2 BTcP Trial</description>
    </item>
  </channel>
</rss>